What Routine Bloodwork Can Show

The tests you get at an annual physical (CBC, liver panel, kidney panel) are designed to check on your organs and general health, not screen for cancer. They can still pick up patterns that prompt a deeper look.

The Usual Tests

• CBC: counts your red cells, white cells, and platelets. Extremely high or low white cell counts can be the first sign of a blood cancer like leukemia or lymphoma.
• Liver panel: measures ALT, AST, and bilirubin. Persistent unexplained elevations can point to liver damage, including liver cancer or cancer that's spread to the liver.
• Kidney panel: creatinine and BUN. Abnormal kidney function can occasionally reflect kidney cancer or metastatic disease affecting the kidneys.

Clues That Might Suggest Cancer

None of these are diagnostic, but they can prompt further testing:

• Strikingly abnormal blood counts: very high or very low white cells, low platelets, unexplained anemia.
• Persistently elevated liver enzymes with no obvious explanation like alcohol or hepatitis.
• Worsening kidney function without an obvious cause.

These findings get a lot more attention in someone with cancer risk factors or matching symptoms. In someone otherwise healthy, the same numbers often have boring explanations.

Cancers That Sometimes Show Up on Routine Bloodwork

Blood Cancers

Leukemia and lymphoma are the cancers most often picked up by a CBC because they affect blood cell production directly. In leukemia, bone marrow churns out abnormal white cells that crowd out healthy ones. The CBC often shows a strikingly high or low white count along with low red cells and platelets. Confirmation usually requires a bone marrow biopsy.

Lymphoma is trickier. It can show up as elevated white counts or high LDH (lactate dehydrogenase), but often the CBC is normal and a swollen lymph node prompts imaging and biopsy instead.

Solid Tumors With Indirect Signs

• Liver cancer or liver metastases: persistent unexplained ALT, AST, or bilirubin elevations.
• Kidney cancer: rising creatinine or BUN without an obvious cause.
• Pancreatic cancer: a tumor near the bile duct can block flow and cause jaundice with elevated bilirubin. CA 19-9 is a more specific marker that's sometimes added if pancreatic cancer is suspected.

None of these confirm cancer. They're flags. Confirmation always means imaging, biopsy, or specialized tests.

Why Routine Bloodwork Isn't Enough for Cancer

The big limitation is specificity. Routine tests measure general organ function and blood cell counts. They can't distinguish cancer from a long list of non-cancer explanations.

Same Abnormality, Many Causes

A high white cell count could be cancer, but it's usually infection, inflammation, or even a recent steroid dose. Elevated liver enzymes are far more often from medication, fatty liver, or alcohol than cancer. Without other supporting evidence, abnormal results lead to repeat testing and a workup, not a cancer diagnosis.

No Direct Cancer Markers in a Standard Panel

Tumor markers like PSA and CA-125 aren't part of a standard CBC or metabolic panel. Those tests get ordered separately when there's a specific reason to look. The standard panels just don't have a "cancer light" to flash.

The Next Step Is Usually Imaging or Biopsy

If something looks wrong on bloodwork and the doctor wants to rule out cancer, the next step is typically imaging (CT, MRI, ultrasound) or a tissue biopsy. Blood tests can suggest where to look. Confirming what's there requires seeing it.

Context Changes Everything

The same abnormal result means different things in different people. Mild liver enzyme elevation in a healthy 30-year-old usually gets a follow-up test and a "let's see in 3 months." The same result in a 70-year-old with weight loss and family history of cancer triggers urgent imaging. Risk factors, symptoms, and trends over time all shape what gets investigated.

Cancer-Specific Blood Tests

When there's a real reason to look for cancer, doctors order more targeted tests.

Tumor Markers

These are substances cancer cells (or the body's response to them) put into the blood. They aren't perfect, but they're more focused than a CBC:

• PSA: screening and monitoring prostate cancer. Benign prostate enlargement also raises PSA, so the result needs context.
• CA-125: monitors ovarian cancer. Can be elevated in endometriosis and other benign conditions.
• CEA: used in colorectal, lung, and breast cancers, mostly for monitoring response to treatment or watching for recurrence. Smoking can also elevate it.
• AFP: liver cancer and certain testicular cancers, especially in people with chronic liver disease.

Liquid Biopsies

A newer category of tests that pick up cancer DNA or whole cancer cells circulating in the blood:

• Circulating tumor DNA (ctDNA): identifies specific mutations from cancer cells. Useful for guiding targeted therapy and tracking residual disease.
• Circulating tumor cells (CTCs): actual cancer cells that have detached from a tumor. Helps assess whether cancer has spread.

Liquid biopsies aren't yet a routine screening tool. They're most useful in people already diagnosed, to guide treatment decisions.

The Limits

Tumor markers can be elevated in non-cancer conditions, and not every cancer produces a detectable marker. Liquid biopsies are improving but still expensive and not widely available for screening. None of these replace imaging or biopsy when cancer needs to be confirmed.

When to Talk to Your Doctor About Cancer Screening

Symptoms Worth Bringing Up

Most of these can have boring explanations, but persistent or unexplained versions deserve a conversation:

• Unexplained weight loss
• Persistent fatigue that doesn't improve with rest
• Abnormal bleeding (in stool, urine, between periods)
• New lumps or masses
• Persistent pain in one area

Higher-Risk Profiles

• Strong family history of cancer (multiple relatives or early-onset)
• Personal history of cancer
• Smoking
• Chronic hepatitis B or C
• Prolonged exposure to carcinogens like asbestos

People in these groups may need earlier or more frequent screening than the general population.

Standard Screening by Age

In Canada, common recommended screenings include:

• Colonoscopy or FIT: starting at 50 for colorectal cancer.
• Mammograms: starting between 40 and 50 for breast cancer, depending on guidelines and personal risk.
• Cervical screening (Pap/HPV testing): starting at 25 for cervical cancer.
• Low-dose CT: for heavy smokers, to screen for lung cancer.

Specialized Testing

Genetic testing (BRCA1/BRCA2 for breast and ovarian cancer, Lynch syndrome for colorectal) can change screening recommendations significantly for people with a strong family history. People with chronic liver disease often get periodic AFP and liver ultrasound.

The Bottom Line

Routine bloodwork isn't a cancer screen, but it's not useless either. It can flag the blood cancers, hint at organ involvement, and trigger follow-up that catches problems earlier. For specific cancers, dedicated screening tools (colonoscopy, mammogram, Pap, low-dose CT, PSA) do the real work. If you have symptoms, risk factors, or a family history, talk to your doctor about what makes sense for you.

Disclaimer: This blog post is intended for educational purposes only and should not be taken as medical advice. Always consult your healthcare provider for personal health concerns.